EMA—a Pioneer Permanently At Bay
Agency's plan for reporting clinical trial data has sparked strong reactions from health campaigners, industry, and patients.
Outrage Grows Over Drug Pricing
Insurers, physicians attack high-cost therapies in anticipation of specialty drug surge.
Sales Reps and the New Commercial Organization
By rethinking the role of the sales rep and the new skills it demands, pharma companies can put themselves in a prime competitive position.
Digital's Place in the Pharma Marketing Mix
The rush to digital will continue at a fast clip, but marketers need to reacquaint themselves with their brands' audiences.
Pharma Science: It's Hard
Amid a resurgence in drug development for hard-to-treat conditions, the bigger question is whether the times are as good for the industry tasked with rendering basic science into therapeutically effective medicines.
